期刊文献+

依达拉奉对脂多糖诱导的PD大鼠模型神经保护作用的实验研究 被引量:5

The experimental study of neurons protective effect of edaravone on the PD rats induced by lipopolysaccharide
下载PDF
导出
摘要 目的研究依达拉奉对脂多糖(LPS)诱导的帕金森病(PD)大鼠模型的保护作用及机制。方法大鼠黑质内立体定向注射14μg LPS建立PD大鼠模型。选取造模成功PD大鼠24只,随机分成大、小剂量组和未治疗组。3组大鼠分别接受不同剂量的依达拉奉注射液(5.0mg/kg,1.0mg/kg)或生理盐水;另外选取正常大鼠5只,作为正常对照组。注射4w后观察各组大鼠黑质酪氨酸羟化酶(TH)阳性细胞的数量以及超氧化物歧化酶(SOD)及丙二醛(MDA)表达变化。结果与未治疗组相比,依达拉奉大、小剂量组TH阳性细胞数显著增多,SOD表达也明显增多(P<0.05),MDA表达明显减少(P<0.05)。结论依达拉奉可能通过减少LPS诱导的自由基产生而对PD大鼠发挥神经保护作用。 Objective To explore the protective effect of the edaravone on dopaminergic neurons of the PD rats in- duced by lipopolysaccharide(LPS). Methods The rat model of PD was established after intranigral injection of 15p, g LPS. Twenty-four female PD rats were randomly divided into three groups with different injection dose of edaravone (5.0mg/kg, 1.0mg/kg) and the injection of saline as control. Five normal rats were set as normal group. On 28d, the num- ber of tyrosine hydroxylase (TH) positive neurons and superoxide dismutase (SOD) and malondialdehyde ( MDA ) in the sub- stantia nigra(SN)were observed. Results The TH positive neurons survived in the animals treated with edaravone were more than those of the saline group (P 〈 0.05 ). The SOD levers of edaravone groups was higher, while MDA level was lower than the saline group( P 〈 0.05 ). Conclusion Edaravone attenuates LPS-induced degeneration of rat substantia nigral dopaminergic neurons.
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2011年第1期53-54,共2页 Journal of Apoplexy and Nervous Diseases
关键词 依达拉奉 脂多糖 帕金森病 大鼠 Edaravone Lipopolysaccharide Parkinsons' disease Rat
  • 相关文献

参考文献1

二级参考文献15

  • 1刘秀华,唐朝枢.缺血再灌注损伤的防治——从实验室到临床[J].中华心血管病杂志,2006,34(8):677-679. 被引量:33
  • 2赵秀梅,孙胜,刘秀华.垫扎球囊法复制大鼠在体心肌缺血/再灌注模型[J].中国微循环,2007,11(3):206-208. 被引量:45
  • 3Zhao ZQ,Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion : comparison with ischemic preconditioning. Am J Physiol (Heart Circ Physiol) ,2003,285:579-588.
  • 4Vinten-Johansen J, Zhao ZQ, Zatta AJ,et al. Postconditioning a new link in nature's armor against myocardial ischemia-reperfusion injury. Basic Res Cardiol,2005, 100: 295-310.
  • 5Zhao ZQ, Vinten-Johansen J. Postconditioning: reduction of reperfusion-induced injury. Cariovasc Res,2006,70:200-211.
  • 6Staat P,Rioufol G, Piot C, et al. Postconditioning the human heart. Circulation,2005,112:2143-2148.
  • 7Kloner RA, Rezkalla SH. Preconditioning, postconditioning and their application to clinical cardiology. Cardiovasc Res,2006,70: 297 -307.
  • 8Higashi Y, Jitsuiki D, Chayama K, et al. Edaravone(3-methyl-1- phenyl-2-pyrazolin-one), a novel free radical scavenger, for treatment of eardiovasc diseases. Recent Patents Cardiovasc Drug Discov, 2006, 1, 85-93.
  • 9Griending KK, Alexander RW. Oxidative stress and cardiovascular disease. Circulation, 1997,96:3264-3265.
  • 10Kin H,ZhaoZQ, Sun HY, et al. Postconditioning attenuates myocardial ischemia reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res,2004,62:74-85.

共引文献22

同被引文献41

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部